Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Sulfadiazine EP

Sulfadiazine EP

68-35-9

DISCOVER
Sotalol HCl D6

Sotalol HCl D6

1246820-85-8

DISCOVER
Sildenafil impurity A EP

Sildenafil impurity A EP

NA

DISCOVER
Sotalol D7 HCl

Sotalol D7 HCl

1398065-65-0

DISCOVER
Sulbactam Sodium Salt

Sulbactam Sodium Salt

69388-84-7

DISCOVER
Sunitinib

Sunitinib

557795-19-4

DISCOVER
Sodium Cyclamate USP

Sodium Cyclamate USP

139-05-9

DISCOVER
Sorafenib

Sorafenib

284461-73-0

DISCOVER
Serricornine

Serricornine

72522-40-8

DISCOVER
Sulfaclozine sodium monohydrate

Sulfaclozine sodium monohydrate

1392129-96-2

DISCOVER
Ethyl Salicylate

Ethyl Salicylate

118-61-6

DISCOVER
(N,N-didemethyl) 1-Hydroxy Sibutramine Hydrocholride

(N,N-didemethyl) 1-Hydroxy Sibutramine Hydrocholride

186521-88-0

DISCOVER